Ya-Tao Wang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 8

Top Topics

Capillary Electrophoresis

Palliative Care

Top Venues

Molecules (Basel, Switzerland)

Natural product reports

This page only lists publications with an associated author ORCID identifier.

Publications

Ya-Tao Wang, Peng-Cheng Yang, Jing-Yi Zhang, Jin-Feng Sun
Synthetic Routes and Clinical Application of Representative Small-Molecule EGFR Inhibitors for Cancer Therapy. Molecules (Basel, Switzerland) 29 (7) (2024)
Zhen-Xi Niu, Ya-Tao Wang, Jun-Feng Wang
Recent advances in total synthesis of protoberberine and chiral tetrahydroberberine alkaloids. Natural product reports (2024)
Ya-Tao Wang, Shi-Qi Jiang, Shao-Lin Zhang
Synthetic Approaches and Clinical Application of Representative Small-Molecule Inhibitors of Cyclin-Dependent Kinase for Cancer Therapy. Molecules (Basel, Switzerland) 29 (13) (2024)
Ya-Tao Wang, Peng-Cheng Yang, Jing-Yi Zhang, Jin-Feng Sun
Synthetic Routes and Clinical Application of Representative Small-Molecule EGFR Inhibitors for Cancer Therapy. Molecules (Basel, Switzerland) 29 (7) (2024)
Ya-Tao Wang, Peng-Cheng Yang, Jing-Yi Zhang, Jin-Feng Sun
Synthetic Routes and Clinical Application of Representative Small-Molecule EGFR Inhibitors for Cancer Therapy. Molecules (Basel, Switzerland) 29 (7) (2024)
Ya-Tao Wang, Shi-Qi Jiang, Shao-Lin Zhang
Synthetic Approaches and Clinical Application of Representative Small-Molecule Inhibitors of Cyclin-Dependent Kinase for Cancer Therapy. Molecules (Basel, Switzerland) 29 (13) (2024)
Zhen-Xi Niu, Ya-Tao Wang, Jun-Feng Wang
Recent advances in total synthesis of protoberberine and chiral tetrahydroberberine alkaloids. Natural product reports (2024)
Ya-Tao Wang, Shi-Qi Jiang, Shao-Lin Zhang
Synthetic Approaches and Clinical Application of Representative Small-Molecule Inhibitors of Cyclin-Dependent Kinase for Cancer Therapy. Molecules (Basel, Switzerland) 29 (13) (2024)